3.3. Assessment of the Differences in the Percentage of TLR-2, TLR-3, TLR-4, and TLR-9 on DCs and Monocytes and the Concentration of Soluble Forms in Serum between Patients with GC Depending on the Type of Cancer and the Stage of the Disease. This evidence concerns the gene TLR2 and cancer.